# Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss

> **NCT00163137** · PHASE3 · COMPLETED · sponsor: **Ligand Pharmaceuticals** · enrollment: 540 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** lasofoxifene
- **DRUG:** raloxifene
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00163137
- **Lead sponsor:** Ligand Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 540 (ACTUAL)
- **Last updated:** 2011-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163137, "Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00163137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*